MedPath

Propranolol for Treatment of Cocaine Addiction - 2

Phase 2
Completed
Conditions
Cocaine-Related Disorders
Registration Number
NCT00000197
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Brief Summary

The purpose of this study is to evaluate the safety and efficacy of propanolol in the early treatment of cocaine dependence.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Cocaine use
Cocaine craving
Mood and anxiety
Side effects
Clinical improvement
Cocaine withdrawal
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of Pennsylvania

🇺🇸

Philadelphia, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath